← Back to directory

Arndt Hartmann

Researcher Next ID · RN-032039

Researcher · Medicine

Friedrich-Alexander-Universität Erlangen-Nürnberg

Erlangen, Germany

Accepting doctoral researchersFunding unknown
Works count
2,385
Citation count
45,839
H-index
99
i10-index
632

Research interests

Medicine
Bladder and Urothelial Cancer Treatments
Urinary and Genital Oncology Studies
Cancer Immunotherapy and Biomarkers
Renal cell carcinoma treatment
Ovarian cancer diagnosis and treatment

Publications

  • The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

    European Urology · 2022 · 10.1016/j.eururo.2022.06.016

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

    Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.03205

  • STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis

    Gut · 2019 · 10.1136/gutjnl-2019-319200

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    The Lancet · 2018 · 10.1016/s0140-6736(18)30789-x

  • Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30904-x

  • Multispectral Optoacoustic Tomography for Assessment of Crohn’s Disease Activity

    New England Journal of Medicine · 2017 · 10.1056/nejmc1612455

  • Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.3290

  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

    Modern Pathology · 2017 · 10.1038/modpathol.2017.46

  • Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome

    The American Journal of Surgical Pathology · 2016 · https://doi.org/10.1097/pas.0000000000000617

  • Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma

    The American Journal of Surgical Pathology · 2014 · https://doi.org/10.1097/pas.0000000000000292

  • Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad

    Endocrine Related Cancer · 2014 · https://doi.org/10.1530/erc-14-0254

  • Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

    The Journal of Pathology · 2013 · 10.1002/path.4287

  • Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection

    PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0029770

  • Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

    Human Molecular Genetics · 2011 · https://doi.org/10.1093/hmg/ddr228

  • Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

    BMC Cancer · 2011 · https://doi.org/10.1186/1471-2407-11-486

  • GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis

    American Journal Of Pathology · 2009 · 10.2353/ajpath.2009.080596

  • Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) Are Common in Adults and Frequently Show c-KIT Mutations

    The American Journal of Surgical Pathology · 2006 · 10.1097/01.pas.0000213307.05811.f0

Current projects

    No projects listed.